1 何鑫,陶绘丞,刘晨,等.医院机会性筛查人群HR-HPV感染的流行病学特征及与宫颈癌前病变的关系.首都医科大学学报,2015,36:219-225.
2 许惠惠,朱海燕,章彤彤,等.高危型人乳头状瘤病毒感染在宫颈病变进展中的风险研究.中华实验和临床病毒学杂志,2017,31:302-306.
3 杨明珠,李亚军,王文素.女性 HPV 亚型的感染情况及与宫颈癌的相关性.中国实验诊断学,2016,20:1331-1333.
4 中华医学会妇产科学分会感染性疾病协作组.阴道微生态评价的临床应用专家共识.中华妇产科杂志,2016,51:721-723.
5 潘颖,盛华芳,康玲,等.高危型人乳头状瘤病毒感染与阴道菌群的相关性研究.第三军医大学学报,2016,8:1559-1564.
6 张岱.阴道微生态诊断评价的关键问题.中国实用妇科与产科杂志,2017,33:785-787.
7 Lowy DR,Sedman S A,Cohen B D,et al.Human papillomaviruses and cancer.Radiother Oncol,2013,108:397-402.
8 谢建萍,杨志红,伊芳,等.宫颈高危型人乳头瘤病毒感染与阴道菌群及宫颈局部免疫功能的关系.中华医院感染学杂志,2017,27:2336-2339.
9 Lee JE,Lee S,Lee H,et al.Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort.Plos One,2013,8:e63514.
10 Wohlmeister D,Vianna DR,Helfer VE,et al.Association of human papillomavirus and Chlamydiatrachomatis with intraepithelial alterations in cervix samples.Mem Inst Oswaldo Cruz,2016,111:106-113.
11 努尔比亚阿布拉,姚丽艳.生殖道HPV与其它病原体感染关系的探讨.中华全科医学,2014,12:942-944.
12 文彩荷,何莲芝.HPV感染与生殖道其他常见病原菌感染关系的研究.中国妇幼保健,2013,28:3985-3988.
13 黄海霞,李桂玲.宫颈癌的免疫学发病机制和疫苗的研究进展.中国免疫学杂志,2015,31:1278-1282.
14 Al-taei S,Banner R,Powell N,et al.Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy.Cancer Immunol Immunother,2013,62:1821-1830.
15 Monnier-Benoit S,Mauny F,Riethmuller D,et al.Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix.Gynecol Oncol,2006,102:22-31.
16 石婷婷,曾丽英,莫芸,等.生活方式干预与细胞免疫功能的相关性研究.分子诊断与治疗杂志,2013,6:398-401.
